Home  »  Company  »  Bliss GVS Pharma Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Bliss GVS Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 598.34 636.36 465.51 441.95 426.59
Manufacturing Expenses 5.80 7.09 6.99 4.70 3.57
Personnel Expenses 72.54 65.06 58.61 44.02 33.85
Selling Expenses 0.50 0.14 0.17 0.56 0.38
Administrative Expenses 114.45 110.92 54.98 55.78 70.55
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 508.18 527.16 374.05 341.78 333.49
Operating Profit 90.16 109.20 91.46 100.17 93.10
Other Recurring Income 50.77 32.63 17.68 37 35.81
Adjusted PBDIT 140.92 141.83 109.14 137.17 128.91
Financial Expenses 10.06 4.32 4.19 6.62 3.15
Depreciation 15.17 13.85 13.76 8.83 5.75
Other Write offs 0 0 0 0 0
Adjusted PBT 115.69 123.66 91.19 121.71 120.01
Tax Charges 30.21 33.74 23.69 29.38 45.58
Adjusted PAT 85.48 89.92 67.50 92.33 74.43
Non Recurring Items -0.67 3.05 0.52 -0.26 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 85.48 92.66 67.50 92.33 74.43
Equity Dividend 5.19 5.18 5.16 12.41 8.22
Preference Dividend 0 0 0 0 0
Retained Earnings 844.96 764.02 676.22 613.36 535.92

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X